An open label randomised controlled study to evaluate the induction of immune memory following infant vaccination with a glyco-conjugate Neisseria meningitidis serogroup C vaccine and to assess the immune response to the concurrent infant routine immunisations administered in consistent versus alternating limbs

Trial Profile

An open label randomised controlled study to evaluate the induction of immune memory following infant vaccination with a glyco-conjugate Neisseria meningitidis serogroup C vaccine and to assess the immune response to the concurrent infant routine immunisations administered in consistent versus alternating limbs

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Hib-DTaP-poliovirus vaccine (Primary) ; Meningococcal vaccine group C conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
  • Indications Diphtheria; Haemophilus infections; Meningococcal group C infections; Pertussis; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 08 Dec 2012 Planned End Date changed from 31 Jul 2011 to 27 Jul 2011 as reported by United Kingdom Clinical Research Network.
    • 27 Aug 2011 United Kingdom Clinical Research Network reports accrual to date changed from 89% to 90%.
    • 17 Aug 2011 Planned end date changed from 31 Mar 2011 to 29 Jul 2011 as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top